Related Experiment Video
Updated: Feb 8, 2026

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
The protective role of curcumin in myocardial ischemia-reperfusion injury
Amin Mokhtari-Zaer1, Narges Marefati1, Stephen L Atkin2
1Department of Physiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Insights
Curcumin shows promise in protecting the heart from ischemia-reperfusion injury, a key issue in coronary artery disease. Further research is needed to determine optimal curcumin regimens for heart protection.
Area of Science:
- Cardiovascular Research
- Pharmacology
Background:
- Coronary artery disease (CAD) presents significant morbidity and mortality.
- Myocardial injury from ischemia-reperfusion (I-R) is a primary manifestation of CAD.
- Effective treatments to protect the heart against myocardial I-R injury are currently lacking.
Purpose of the Study:
- To review the pathophysiology of myocardial I-R injury.
- To explore the cardioprotective mechanisms of curcumin.
- To identify potential curcumin regimens for mitigating myocardial I-R injury.
Main Methods:
- Literature review of experimental evidence on curcumin and cardiovascular health.
- Analysis of studies investigating curcumin's effects on myocardial I-R injury.
- Examination of curcumin's phytochemical properties and mechanisms of action.
Main Results:
- Experimental data suggest curcumin possesses cardioprotective properties.
- Curcumin may modify cardiovascular risk factors.
- The precise role and optimal regimen of curcumin in myocardial I-R injury require further elucidation.
Conclusions:
- Curcumin demonstrates potential for reducing myocardial I-R injury.
- Understanding curcumin's mechanisms is crucial for developing novel cardioprotective strategies.
- Further investigation is warranted to establish curcumin's clinical utility in CAD patients experiencing I-R events.
Abstract:
Coronary artery disease (CAD) is a well-known pathological condition that is characterized by high morbidity and mortality. The main pathological manifestation of CAD is myocardial injury due to ischemia-reperfusion (I-R). Currently, no efficacious treatment of protecting the heart against myocardial I-R exists. Hence, it is necessary to discover or develop novel strategies to prevent myocardial-reperfusion injury to improve clinical outcomes in patients with CAD. A large body of experimental evidence supports cardioprotective properties of curcumin and the ability of this phytochemical to modify some cardiovascular risk factors. However, the detailed effects of curcumin in myocardial I-R injury are still unclear and there is a lack of evidence concerning which curcumin regimen may be ideal for myocardial I-R injury. This paper presents a brief review of the pathophysiology of myocardial I-R injury and the mechanisms of action of curcumin in reducing myocardial I-R injury.
Related Concept Videos
Protection of Alcohols
Protection
It defines a protecting group as the masking agent to make the more reactive species inert to a given set of conditions. This concept is depicted via the illustration of liquid flow through different outlets in an assembly of pipes. The analogy helps to understand the role...
Zones of Protection
Protective zones are defined by closed dashed lines, containing one or more components. A key characteristic of these zones is the strategic placement of...
Radial System Protection
In a radial system with a fault downstream of the third breaker, ideally, only the third breaker will open, isolating the fault and interrupting the load connected beyond it. The second breaker has a longer delay setting,...
Protecting Self-Esteem
Line Protection with Impedance Relays
Under normal conditions, low load currents keep the measured...
Personal Protective Equipment

